# Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris

> **NCT05409365** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 50 (estimated)

## Conditions studied

- Verruca Vulgaris
- Healthy

## Interventions

- **OTHER:** Immunohistochemical staining monoclonal antibodies to SCCA2 (SERPINB4/ SCCA2 antibody)

## Key facts

- **NCT ID:** NCT05409365
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05409365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05409365, "Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05409365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*